Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could when you eat help control diabetes? new study tests meal timing vs. calorie counting

NCT ID NCT07674875

Disease control Sponsor: Akdeniz University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This trial investigates whether changing how often and when people with type 2 diabetes eat can improve weight, blood sugar, and cholesterol. Over 12 weeks, participants follow one of three eating plans: a standard 6-meal diet, a 3-meal diet, or time-restricted eating (eating all food within an 8-hour window). The study compares these approaches to see which works best for managing diabetes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
dietary intervention (meal frequency and timing)
What this could lead to
If successful, this could point toward a simple, non-drug way to help manage type 2 diabetes by adjusting when and how often people eat.
What could go wrong
This is a small, 12-week study, so long-term effects are unknown. Results may not apply to everyone, and sticking to the eating plans may be hard for some.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

144 people

The number who actually took part.

Started

Mar 2024

Finished

Nov 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 to 64 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosed with Type 2 Diabetes Mellitus (T2DM) for at least 6 months. * Aged between 18 and 65 years. * Residing in Antalya, Turkey (to ensure regular follow-up visits). * Able and willing to provide informed consent. * Willing to comply with the assigned dietary protocol and follow-up measurements for 12 weeks. Exclusion Criteria: * Diagnosis of Type 1 Diabetes Mellitus or other specific types of diabetes. * Current pregnancy or breastfeeding. * Working in night shifts or irregular schedules (due to interference with Time-Restricted Eating protocols). * Having a history of major cardiovascular events (e.g., myocardial infarction, stroke) within the last 6 months. * Severe renal or hepatic impairment (e.g., Stage 4 or 5 Chronic Kidney Disease). * Active malignancy or other chronic diseases that may significantly affect nutritional status. * Significant weight change (more than 5% of body weight) within the last 3 months prior to the study. * Use of medications that may significantly affect body weight or metabolism other than standard diabetes medications (e.g., systemic corticosteroids). * History of major gastrointestinal surgery that affects nutrient absorption. * Severe psychiatric disorders that may limit the ability to follow the study instructions.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Obesity and overweight are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Intermittent Fasting Obesity obesity disorder Overweight type 2 diabetes mellitus Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Obesity and overweight Type 2 diabetes

Contacts and locations

Locations

  • Akdeniz University Faculty of Medicine

    Antalya, Konyaalti, 07070, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.